A Real-World, Observational, Prospective Study to Assess the Molecular Epidemiology of Epidermal Growth Factor Receptor (EGFR) Mutations upon Progression on or after First-Line Therapy with a First- or Second-Generation EGFR Tyrosine Kinase Inhibitor in EGFR Mutation-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer: The 'LUNGFUL' Study
一项真实世界、观察性、前瞻性研究，旨在评估表皮生长因子受体 (EGFR) 突变阳性的局部晚期或转移性非小细胞肺癌患者在接受一线治疗（第一代或第二代 EGFR 酪氨酸激酶抑制剂）后疾病进展时 EGFR 突变的分子流行病学特征：LUNGFUL 研究
期刊:Cancers
影响因子:4.4
doi:10.3390/cancers13133172
Mountzios, Giannis; Koumarianou, Anna; Bokas, Alexandros; Mavroudis, Dimitrios; Samantas, Epaminondas; Fergadis, Evangelos Georgios; Linardou, Helena; Katsaounis, Panagiotis; Athanasiadis, Elias; Karamouzis, Michalis V; Pentheroudakis, George; Lampaki, Sofia; Froudarakis, Marios E; Perdikouri, Eleni-Isidora A; Somarakis, Alvertos; Papageorgiou, Foteini; Paparepa, Zoe; Nikolaou, Aristeidis; Syrigos, Konstantinos N
信号转导
EGFR
肺癌
EGF
肿瘤
细胞生物学
肿瘤免疫
NGF
